DCTH
Delcath Systems, Inc. - Common Stock (DCTH)
$11
About Delcath Systems, Inc. - Common Stock (DCTH)
Delcath Systems, Inc. is an oncology company, which engages in the treatment of primary and metastatic liver cancers. Its products include CHEMOSAT and HEPZATO. The company was founded on August 5, 1988 and is headquartered in Queensbury, NY.
Details
Daily high
$16.25
Daily low
$15.87
Price at open
$16.25
52 Week High
$17.42
52 Week Low
$8.12
Market cap
559.0M
Dividend yield
-
Volume
365,511
Avg. volume
398,293
P/E ratio
2,640.98
Delcath Systems, Inc. - Common Stock News
Details
Daily high
$16.25
Daily low
$15.87
Price at open
$16.25
52 Week High
$17.42
52 Week Low
$8.12
Market cap
559.0M
Dividend yield
-
Volume
365,511
Avg. volume
398,293
P/E ratio
2,640.98